Viewing Study NCT03910361


Ignite Creation Date: 2025-12-24 @ 12:55 PM
Ignite Modification Date: 2026-02-21 @ 11:46 AM
Study NCT ID: NCT03910361
Status: COMPLETED
Last Update Posted: 2021-04-29
First Post: 2019-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
Sponsor: Dong-A ST Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type2 Diabetes View
None Non-Alcoholic Fatty Liver Disease View
Keywords: